Chemo for lung cancer: the fastest‑growing frontier
Lung cancer kills more people than any other cancer. And while immunotherapy and targeted therapy are exciting, chemotherapy remains essential — especially for small cell lung cancer (SCLC) and advanced non‑small cell lung cancer (NSCLC). The chemotherapy market forecast shows that lung cancer is the fastest‑growing indication, with a CAGR above 7.5%. Why? Because rates are...
0 Σχόλια 0 Μοιράστηκε 42 Views 0 Προεπισκόπηση